Is CRON or ORIC more profitable?

CRON runs the higher net margin — CRON at 30.98% versus ORIC at 0.00%.

How have CRON and ORIC total returns compared?

Over the past 5 years, CRON delivered -9.92% and ORIC delivered -8.73% annualized total return. Past performance doesn't predict future results.

Cronos Group Inc. (CRON) vs ORIC Pharmaceuticals, Inc. (ORIC)

A side-by-side comparison of Cronos Group Inc. and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CRON

Cronos Group Inc.

$1.22B

$3.27HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

ORIC

ORIC Pharmaceuticals, Inc.

$1.24B

$11.96HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT

Total return — CRON vs ORIC

growth of $100 · dividends reinvested · last 6y

CRON -44.9% (-9.5%/yr)ORIC -51.5% (-11.4%/yr)CRON compounded faster over this window

CRON ORIC

CRON vs ORIC: by the numbers

•ORIC is the larger company ($1.24B vs $1.22B market cap).
•CRON is profitable (30.98% net margin) while ORIC runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	CRON	ORIC
P/E ratio	18.06	N/A
P/S ratio	5.42	N/A
P/B ratio	1.14	3.25
EV / EBITDA	27.88	N/A
FCF yield	4.07%	N/A

Profitability

Metric	CRON	ORIC
Gross margin	36.16%	0.00%
Operating margin	-11.96%	0.00%
Net margin	30.98%	0.00%
ROE	6.53%	-36.81%
ROIC	1.12%	-40.32%

Growth (annualized)

Metric	CRON	ORIC
Revenue CAGR (5Y)	31.80%	N/A
Total return CAGR (5Y)	-9.92%	-8.73%

Frequently asked

Is CRON or ORIC more profitable?: CRON runs the higher net margin — CRON at 30.98% versus ORIC at 0.00%.
How have CRON and ORIC total returns compared?: Over the past 5 years, CRON delivered -9.92% and ORIC delivered -8.73% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CRON analysis Full ORIC analysis Interactive comparison tool

Dig into the metrics

Cronos P/E ratio Cronos ROE ORIC Pharmaceuticals ROE Cronos operating margin ORIC Pharmaceuticals operating margin Cronos revenue growth ORIC Pharmaceuticals revenue growth Cronos free cash flow ORIC Pharmaceuticals free cash flow

Cronos & ORIC Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.